Lupin Atlantis Holdings S.A. v. InvaGen Pharmaceuticals Inc. > Summary
Court Case Number 1:16-cv-00708
Filing Date Aug 11, 2016
Court Delaware District Court
Status Unknown
Plaintiff
Defendant
Plaintiff Attorneys
7Lupin Atlantis Holdings SA
Attorney Name: Megan C. Haney
Phillips, McLaughlin & Hall, P.A.
Lupin Atlantis Holdings SA
Attorney Name: Elizabeth J. Holland
Goodwin Procter LLP
Lupin Atlantis Holdings SA
Attorney Name: Brigid M. Morris
Goodwin Procter LLP
Lupin Atlantis Holdings SA
Attorney Name: Christopher J. Morten
Goodwin Procter LLP
Lupin Atlantis Holdings SA
Attorney Name: John C. Phillips, Jr.
Phillips, McLaughlin & Hall, P.A.
Lupin Atlantis Holdings SA
Attorney Name: Emily L. Rapalino
Goodwin Procter LLP
Defendant Attorneys
5InvaGen Pharmaceuticals, Inc.
Attorney Name: R. Touhey Myer
Caesar Rivise
InvaGen Pharmaceuticals, Inc.
Attorney Name: Robert S. Silver
Caesar Rivise
InvaGen Pharmaceuticals, Inc.
Attorney Name: Lynn M. Terrebonne
Caesar Rivise
InvaGen Pharmaceuticals, Inc.
Attorney Name: Pei-ru Wey
Caesar Rivise
Counter Defendant
Counter Claimant
InvaGen Pharmaceuticals, Inc.
Attorney Name: R. Touhey Myer
Caesar Rivise
Cause
35:271 Patent Infringement
Related Patents
| Doc No | Title | Issue date |
|---|---|---|
| 09314447 | Reduced dose pharmaceutical compositions of fenofibrate | Apr 19, 2016 |
| 08026281 | Treating metabolic syndrome with fenofibrate | Sep 27, 2011 |
